Sernova Biotherapeutics Inc
SEOVF
$0.146
$0.00382.67%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.15% | 18.07% | -8.34% | -29.97% | -46.99% |
| Total Depreciation and Amortization | 7.59% | 20.10% | 9.21% | -4.40% | -5.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.65% | -50.95% | -15.10% | -7.55% | -12.92% |
| Change in Net Operating Assets | -15.85% | 119.93% | 13.70% | 205.06% | 61.42% |
| Cash from Operations | 34.29% | 38.08% | -9.77% | -12.04% | -57.50% |
| Capital Expenditure | -- | -- | 100.00% | 91.64% | 82.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.74% | -68.51% | -48.79% | 172.09% | 154.52% |
| Cash from Investing | -31.59% | -68.42% | -48.56% | 171.71% | 154.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.09% | 1.57% | 0.29% | -0.65% | -1.59% |
| Issuance of Common Stock | -- | -- | -99.87% | -99.96% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.80% | -98.83% | -30.81% | -37.46% | -18.71% |
| Cash from Financing | 3,203.43% | 897.47% | -97.96% | -99.46% | -99.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.93% | -153.25% | -185.35% | 27.27% | -169.25% |